Clinical trial
A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty
NCT02807428 is registered in ClinicalTrials.gov with Adynxx, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty
- Lead sponsor
- Adynxx, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 20, 2017
- Completion date
- December 19, 2017
- Enrollment
- 210 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
post-surgical pain